Literature DB >> 8256790

Osteoporosis in men: epidemiology, pathophysiology, and treatment possibilities.

E Seeman1.   

Abstract

The neglect of the problem of fractures in men may be the result of the focus on the enormity of the problem in women, attention to vertebral fractures and the role of menopause in the pathogenesis of fractures and cardiovascular disease, and the role of hormone replacement therapy in the prevention of fractures and cardiovascular disease. The use of epidemiology as a means of understanding the disease in individuals has confirmed that fractures are a common and serious consequence of osteoporosis in women--and in men.

Entities:  

Mesh:

Year:  1993        PMID: 8256790     DOI: 10.1016/0002-9343(93)90377-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

Review 1.  Male osteoporosis: new trends in diagnosis and therapy.

Authors:  Hosam K Kamel
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Determinants of bone mineral density in Chinese men.

Authors:  E Y N Cheung; A Y Y Ho; K F Lam; S Tam; A W C Kung
Journal:  Osteoporos Int       Date:  2005-08-27       Impact factor: 4.507

Review 3.  Bone loss in men.

Authors:  C Gennari; R Nuti
Journal:  Calcif Tissue Int       Date:  1996-01       Impact factor: 4.333

4.  The determinants of bone mineral density in Chinese men--results from Mr. Os (Hong Kong), the first cohort study on osteoporosis in Asian men.

Authors:  E M C Lau; P C Leung; T Kwok; J Woo; H Lynn; E Orwoll; S Cummings; J Cauley
Journal:  Osteoporos Int       Date:  2005-09-21       Impact factor: 4.507

5.  Fracture epidemiology and control in a developmental center.

Authors:  G S Lohiya; F M Crinella; L Tan-Figueroa; S Caires; S Lohiya
Journal:  West J Med       Date:  1999-04

Review 6.  Male osteoporosis: epidemiology and pathophysiology.

Authors:  Shreyasee Amin
Journal:  Curr Osteoporos Rep       Date:  2003-09       Impact factor: 5.096

7.  The effect of DXA scanning on clinical decision making by general practitioners: a randomized, prospective trial of direct access versus referral to a hospital consultant.

Authors:  V Dhillon; J Creiger; J Hannan; N Hurst; G Nuki
Journal:  Osteoporos Int       Date:  2003-04-29       Impact factor: 4.507

Review 8.  Background to and management of treatment-related bone loss in prostate cancer.

Authors:  Alfredo Berruti; Marcello Tucci; Carlo Terrone; Gabriella Gorzegno; Roberto M Scarpa; Alberto Angeli; Luigi Dogliotti
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

9.  Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?

Authors:  Shaymaa Abdalwahed Abdulameer; Syed Azhar Syed Sulaiman; Mohamed Azmi Ahmad Hassali; Karuppiah Subramaniam; Mohanad Naji Sahib
Journal:  Patient Prefer Adherence       Date:  2012-06-11       Impact factor: 2.711

Review 10.  Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management.

Authors:  P R Ebeling
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 4.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.